Clene Inc.CLNNNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank96
3Y CAGR+47.5%
5Y CAGR+37.5%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+47.5%/yr
vs -3.8%/yr prior
5Y CAGR
+37.5%/yr
Recent acceleration
Acceleration
+51.3pp
Accelerating
Percentile
P96
Near historical high
vs 5Y Ago
4.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 56.65% |
| Q3 2025 | -0.03% |
| Q2 2025 | 137.27% |
| Q1 2025 | -73.40% |
| Q4 2024 | 24.54% |
| Q3 2024 | 7.73% |
| Q2 2024 | -29.29% |
| Q1 2024 | -7.11% |
| Q4 2023 | 5.79% |
| Q3 2023 | -9.72% |
| Q2 2023 | -10.55% |
| Q1 2023 | -1.83% |
| Q4 2022 | 17.65% |
| Q3 2022 | -30.14% |
| Q2 2022 | 6.83% |
| Q1 2022 | -9.90% |
| Q4 2021 | 54.95% |
| Q3 2021 | -5.04% |
| Q2 2021 | 3.14% |
| Q1 2021 | 40.88% |
| Q4 2020 | 11.52% |
| Q3 2020 | 12.38% |
| Q2 2020 | 10.99% |
| Q1 2020 | 0.00% |
| Q4 2019 | -100.00% |
| Q3 2019 | 20.02% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |